Why Scholar Rock Shares Are Soaring Today

Shares of Scholar Rock Holding (NASDAQ: SRRK) are soaring today, up 13.7% as of 1:14 p.m. ET. The move comes as the S&P 500 and Nasdaq Composite were up modestly.
Scholar Rock, a biopharma company, reported positive results from a phase 2 trial of its muscle-preserving weight-loss therapy.
Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now. Continue »
Significant results
The study evaluated Scholar Rock's apitegromab in combination with Eli Lilly 's blockbuster weight-loss drug tirzepatide (sold as Mounjaro and Zepbound). The combo showed a significant reduction in lean mass loss, a major issue with current GLP-1 treatments.
The company says that the trial showed that 30% of the weight lost by users of tirzepatide without apitegromab was lean mass, but that figure was cut in half with the addition of Scholar Rock's drug.
The company said the therapy was generally well tolerated, and that the results show it has "the potential to support healthier weight loss for millions of patients on GLP therapies by safely preserving lean mass."
A massive market
GLP-1 drugs like Eli Lilly's Mounjaro and Novo Nordisk 's Ozempic have been some of the most successful launches of drugs in history. The 2024 market was worth $53.5 billion and is expected to triple in size by 2030. Considering most people's desire to lose fat, not muscle, a drug like Scholar Rock's apitegromab could be massive.
With the development of any drug, nothing is guaranteed. While the results of this trial were encouraging, there is a way to go before full Food and Drug Administration approval and commercialization. I think this is a good pick, albeit one that carries some risk.
Should you invest $1,000 in Scholar Rock right now?
Before you buy stock in Scholar Rock, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Scholar Rock wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $658,297!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $883,386!*
Now, it's worth noting Stock Advisor 's total average return is992% — a market-crushing outperformance compared to172%for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor.
See the 10 stocks »
*Stock Advisor returns as of June 9, 2025

Try Our AI Features

Explore what Daily8 AI can do for you:

Learn with AIFact CheckingText to SpeechAI Summary

Related Articles

Globe and Mail

2 hours ago

• Globe and Mail

New Strong Sell Stocks for June 16th

Here are three stocks added to the Zacks Rank #5 (Strong Sell) List today: ADT Inc. ADT is a smart home solutions providing company. The Zacks Consensus Estimate for its current year earnings has been revised 1.2% downward over the last 60 days. DoubleDown Interactive Co., Ltd. DDI is a digital gaming company. The Zacks Consensus Estimate for its current year earnings has been revised 6.3% downward over the last 60 days. M/I Homes, Inc. MHO is a residential home-builder. The Zacks Consensus Estimate for its current year earnings has been revised 7.8% downward over the last 60 days. View the entire Zacks Rank #5 List. Zacks' Research Chief Names "Stock Most Likely to Double" Our team of experts has just released the 5 stocks with the greatest probability of gaining +100% or more in the coming months. Of those 5, Director of Research Sheraz Mian highlights the one stock set to climb highest. This top pick is a little-known satellite-based communications firm. Space is projected to become a trillion dollar industry, and this company's customer base is growing fast. Analysts have forecasted a major revenue breakout in 2025. Of course, all our elite picks aren't winners but this one could far surpass earlier Zacks' Stocks Set to Double like Hims & Hers Health, which shot up +209%. Free: See Our Top Stock And 4 Runners Up Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report ADT Inc. (ADT): Free Stock Analysis Report M/I Homes, Inc. (MHO): Free Stock Analysis Report DoubleDown Interactive Co., Ltd. Sponsored ADR (DDI): Free Stock Analysis Report This article originally published on Zacks Investment Research (

Globe and Mail

5 hours ago

• Globe and Mail

Is BigBear.ai Stock a Buy Now?

The hot artificial intelligence (AI) market has birthed a number of high-flying AI stocks. One of these is (NYSE: BBAI). The company's share price soared more than 200% over the past 12 months through June 18. The stock hit a 52-week high of $10.36 in February after President Donald Trump announced Project Stargate, which aims to invest billions of dollars into the AI sector. Since then, stock is down more than 50% from its peak. Does this present an opportunity to scoop up the company's shares for cheap? Why shares plummeted A confluence of factors led to the decline in stock this year. One is Wall Street's concerns about the unpredictable macroeconomic environment, exacerbated by the Trump administration's tariff approach. On top of that, the federal government is cutting budgets. This is worrying because delivers AI solutions centered around national security and infrastructure. Consequently, the bulk of company revenue comes from federal government contracts. Adding to this mix, in March, disclosed a material weakness in its internal controls for financial reporting, contributing to the company's share price decline. As a result, the company restated the last few years' worth of financial statements. While unrelated, CFO Julie Peffer departed in June. This wasn't 2025's only leadership change. In January, gained a new CEO, Kevin McAleenan, who had served as Acting Secretary of the U.S. Department of Homeland Security during President Trump's first term. financial picture leadership changes may be a good outcome over the long run. McAleenan's experience with the previous Trump administration could help survive the government budget cuts. In addition, under the previous CEO, the company fell short of its 2024 goal to achieve at least $165 million in sales, coming in at $158.2 million last year. With McAleenan taking over, perhaps can meet its 2025 full-year revenue target, which ranges between $160 million and $180 million. He will have to succeed to win shareholder confidence in his leadership. It's too early to tell if McAleenan can deliver, since he only has the first quarter under his belt. brought in $34.8 million in Q1 sales, a 5% year-over-year increase. However, the company's balance sheet includes a sizable chunk of debt. Of its $198.5 million in total Q1 liabilities, $101.4 million was debt. Q1 total assets were 396.3 million with $107.6 million of that in cash and equivalents. Moreover, despite year-over-year sales growth, is not profitable. It exited Q1 with a net loss of $62 million. Deciding whether to buy stock It's not uncommon for tech companies to operate at a loss, but in these cases, you want to see sales growing rapidly. With just a 5% year-over-year increase in Q1 revenue, is not achieving strong growth, especially for the hot field of artificial intelligence. This raises questions about the company's ability to capture customers, let alone eventually achieve profitability. stock valuation is another factor to consider. The price-to-sales (P/S) ratio is useful for this purpose, since it measures how much investors are willing to pay for every dollar of revenue. This metric is commonly used with companies that aren't profitable. Comparing it to artificial intelligence leader Nvidia, as well as a competitor also operating in the government AI sector, helps to understand share price valuation. Data by YCharts. The chart shows P/S multiple is the lowest of the three AI companies, and it's down significantly from where it was at in February. This suggests shares are attractively valued. However, Nvidia and warrant higher valuations because of their business performance. For example, Nvidia's revenue rose 69% year over year to $44.1 billion in its fiscal Q1, ended April 27. Meanwhile, revenue of $108.7 million in its fiscal fourth quarter, ended April 30, represented a 26% year-over-year increase. mediocre AI revenue growth, debt, and the factors that led to its share price decline this year means investing in the company is risky. As a result, it's best to hold off buying. Instead, watch its business performance over the next few quarters to see if it can strengthen sales before reconsidering stock. Should you invest $1,000 in right now? Before you buy stock in consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $664,089!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $881,731!* Now, it's worth noting Stock Advisor 's total average return is994% — a market-crushing outperformance compared to172%for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of June 9, 2025

CTV News

6 hours ago

• CTV News

Vancouver lawyer suspended for submitting false documents in support of client's $3.3M loan application

A Vancouver lawyer has admitted to improperly notarizing documents and solemnly declaring affidavits that contained information he knew was false in order to help a corporate client secure a $3.3-million loan from a U.S. bank. Jason Chieh-Sheng Wang admitted his misconduct in a consent agreement with the Law Society of B.C., a summary of which was published online last week. According to the document, Wang was retained by 'a group of companies' in April 2023 to facilitate the loan application. 'Upon being retained, the lawyer was advised that the client was in difficult financial circumstances, and that it wished to obtain a loan from the lender on an urgent basis,' the summary reads. The loan was secured by 'five pieces of artwork as collateral,' according to the document. None of the parties involved in the situation – other than Wang himself – are named in the consent agreement summary. Instead, the document uses parties' initials. 'The loan was personally guaranteed by ZYZ and JM, whose respective families held the majority of the shares of the client,' the document reads. 'The loan also required the approval of their respective spouses, YP and LW, documented by spousal consents.' The lender told Wang it needed the spousal consent forms – along with other documents prepared in the U.S. – notarized, something the lawyer said would be impractical because some of the parties whose signatures were required were located in China. The bank eventually agreed that Wang could notarize the signatures in question via video call. Wang 'purported to notarize' four documents on May 15, 2023, but he had not actually met the signatories via video call, or at all, according to the consent agreement summary. The lawyer also created three affidavits in which he swore that the signatories had joined him on a video call and shown him both sides of their government-issued photo IDs before signing the documents. 'The lawyer solemnly declared the contents of the affidavits of execution to be true when he knew that he had not met with any of the signatories … via video conference or at all, and had not witnessed any of their signatures,' the summary reads. Wang also admitted to deleting WeChat messages he had exchanged with the client's representatives, in which he agreed to proceed with notarizing the documents without the requisite video call. 'The lawyer knew or ought to have known that deleting this client correspondence was contrary to his obligation to maintain and preserve his client's files and records," the summary reads. For all of this admitted misconduct, Wang agreed to serve a one-month suspension, which began on June 16. In accepting the consent agreement, the law society's discipline panel considered three mitigating factors: